Skip to main content

Impfmythen in der Pädiatrie

Vaccination myths in pediatrics

This is a preview of subscription content, access via your institution.

Literatur

  1. 1.

    Moss B (2011) Smallpox vaccines: targets of protective immunity. Immunol Rev 239:8–26

    CAS  Article  Google Scholar 

  2. 2.

    Aylward RB, Acharya A, England S, Agocs M, Linkins J (2003) Global health goals: lessons from the worldwide effort to eradicate poliomyelitis. Lancet 362:909–914

    Article  Google Scholar 

  3. 3.

    Barrett S (2004) Eradication versus control: the economics of global infectious disease policies. Bull World Health Organ 82:683–688

    PubMed  PubMed Central  Google Scholar 

  4. 4.

    Wagner KS, White JM, Lucenko I et al (2012) Diphtheria Surveillance Network. Diphtheria in the postepidemic period, Europe, 2000–2009. Emerg Infect Dis 18:217–225

    Article  Google Scholar 

  5. 5.

    Goodson JL, Seward JF (2015) Measles 50 years after use of measles vaccine. Infect Dis Clin North Am 29:725–743

    Article  Google Scholar 

  6. 6.

    Aktuelle Epidemiologie von Masern in Deutschland. Epidemiologische Bulletin 2018(33):325–330

  7. 7.

    WHO (2018) Measles cases hit record high in the European Region. http://www.euro.who.int/en/media-centre/sections/press-releases/2018/measles-cases-hit-record-high-in-the-european-region

    Google Scholar 

  8. 8.

    Metcalf CJ, Ferrari M, Graham AL, Grenfell BT (2015) Understanding herd immunity. Trends Immunol 36:753–755

    CAS  Article  Google Scholar 

  9. 9.

    Rota PA, Moss WJ, Takeda M, de Swart RL, Thompson KM, Goodson JL (2016) Measles. Nat Rev Dis Primers 2:16049. https://doi.org/10.1038/nrdp.2016.49

    Article  PubMed  Google Scholar 

  10. 10.

    Schlaud M, Poethko-Müller C, Kuhnert R, Hecker H (Erscheinungsdatum 24. Januar 2014 beim RKI) Endbericht der TOKEN-Studie. Studie über Todesfälle bei Kindern im 2. bis 24. Lebensmonat. https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/Weitere_Studien/TOKEN_Studie/Studyreport.html

    Google Scholar 

  11. 11.

    Mentzer D, Oberle D, Keller-Stanislawski B (2018) Daten zur Pharmakovigilanz von Impfstoffen aus dem Jahr 2016. Bull Arzneimittelsicherheit 1:17–24

    Google Scholar 

  12. 12.

    Offit PA, Quarles J, Gerber MA, Hackett CJ, Marcuse EK, Kollman TR, Gellin BG, Landry S (2002) Addressing parents’ concerns: do multiple vaccines overwhelm or weaken the infant’s immune system? Pediatrics 109(1):124–129

    Article  Google Scholar 

  13. 13.

    Perricone C, Agmon-Levin N, Shoenfeld Y (2013) Novel pebbles in the mosaic of autoimmunity. Bmc Med 11:101

    CAS  Article  Google Scholar 

  14. 14.

    van der Laan JW, Gould S, Tanir JY, ILSI HESI Vaccines and Adjuvants Safety Project Committee (2015) Safety of vaccine adjuvants: focus on autoimmunity. Vaccine 33:1507–1514

    Article  Google Scholar 

  15. 15.

    Shoenfeld Y, Agmon-Levin N (2011) ‘ASIA’—autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun 36:4–8

    CAS  Article  Google Scholar 

  16. 16.

    Hawkes D, Benhamu J, Sidwell T, Miles R, Dunlop RA (2015) Revisiting adverse reactions to vaccines: a critical appraisal of autoimmune syndrome induced by adjuvants (ASIA). J Autoimmun 59:77–84

    Article  Google Scholar 

  17. 17.

    Pellegrino P, Perrone V, Pozzi M et al (2015) The epidemiological profile of ASIA syndrome after HPV vaccination: an evaluation based on the Vaccine Adverse Event Reporting Systems. Immunol Res 61:90–96

    CAS  Article  Google Scholar 

  18. 18.

    Wakefield AJ, Murch SH, Anthony A et al (1998) Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 351:637–641

    CAS  Article  Google Scholar 

  19. 19.

    Murch SH, Anthony A, Casson DH et al (2004) Retraction of an interpretation. Lancet 363:750

    Article  Google Scholar 

  20. 20.

    The Lancet (2010) Retraction—ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 375:445

    Article  Google Scholar 

  21. 21.

    Parker SK, Schwartz B, Todd J, Pickering LK (2004) Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data. Pediatrics 114:793–804

    Article  Google Scholar 

  22. 22.

    Taylor LE, Swerdfeger AL, Eslick GD (2014) Vaccines are not associated with autism: an evidence-based meta-analysis of case-control and cohort studies. Vaccine 32:3623–3629

    CAS  Article  Google Scholar 

  23. 23.

    Keller-Stanislawski B et al (2014) Safety of immunization during pregnancy: a review of the evidence of selected inactivated and live attenuated vaccines. Vaccine 32(52):7057–7064

    CAS  Article  Google Scholar 

  24. 24.

    Volz-Zang C (2014) Sicherheit von Impfungen während der Schwangerschaft. Bull Zur Arzneimittelsicherheit 4:16–20

    Google Scholar 

  25. 25.

    Polyzos KA, Konstantelias AA, Pitsa CE, Falagas ME (2015) Maternal influenza vaccination and risk for congenital malformations: a systematic review and meta-analysis. Obstet Gynecol 126:1075–1084

    CAS  Article  Google Scholar 

  26. 26.

    Makris MC, Polyzos KA, Mavros MN, Athanasiou S, Rafailidis PI, Falagas ME (2012) Safety of hepatitis B, pneumococcal polysaccharide and meningococcal polysaccharide vaccines in pregnancy: a systematic review. Drug Saf 35:1–14

    CAS  Article  Google Scholar 

  27. 27.

    Castillo-Solorzano C, Reef SE, Morice A et al (2011) Rubella vaccination of unknowingly pregnant women during mass campaigns for rubella and congenital rubella syndrome elimination, the Americas 2001–2008. J Infect Dis 204(Suppl 2):S713–717

    Article  Google Scholar 

  28. 28.

    Wilson E, Goss MA, Marin M et al (2008) Varicella vaccine exposure during pregnancy: data from 10 Years of the pregnancy registry. J Infect Dis 197(Suppl 2):S178–S184

    Article  Google Scholar 

  29. 29.

    Suryadevara M, Domachowske JB (2015) Prevention of pertussis through adult vaccination. Hum Vaccin Immunother 11:1744–1747

    Article  Google Scholar 

  30. 30.

    Centers for Disease Control and Prevention (2011) CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged 〈12 months—Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 60:1424–1426

    Google Scholar 

  31. 31.

    Boylston A (2013) The origins of vaccination: myths and reality. J R Soc Med 106(9):351–354

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to F. Zepp.

Ethics declarations

Interessenkonflikt

F. Zepp ist seit 1998 Mitglied der Ständigen Impfkommission beim RKI.

Dieser Beitrag beinhaltet keine von dem Autor durchgeführten Studien an Menschen oder Tieren.

Additional information

Redaktion

G. Hansen, Hannover

R. Kerbl, Leoben

F. Zepp, Mainz

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zepp, F. Impfmythen in der Pädiatrie. Monatsschr Kinderheilkd 166, 1114–1119 (2018). https://doi.org/10.1007/s00112-018-0610-3

Download citation